{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:45:11Z","timestamp":1776127511208,"version":"3.50.1"},"reference-count":62,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.3892\/etm.2016.3851","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T12:10:56Z","timestamp":1477570256000},"page":"3778-3784","source":"Crossref","is-referenced-by-count":18,"title":["WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma"],"prefix":"10.3892","volume":"12","author":[{"given":"Santiago","family":"Saavedra-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Zapata-Benavides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Karina","family":"Chavez-Escamilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Manilla-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana Elisa","family":"Zamora-Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mois\u00e9s Armides","family":"Franco-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodriguez-Padilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"key20180108133759_b1-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: Biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"key20180108133759_b2-etm-0-0-3851","first-page":"13","article-title":"The mechanisms of UV radiation in the development of malignant melanoma","author":"Situm","year":"2007","journal-title":"Coll Antropol 31 (Suppl 1)"},{"key":"key20180108133759_b3-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Nikolaou","year":"2014","journal-title":"Br J Dermatol"},{"key":"key20180108133759_b4-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2004.03.074","article-title":"Prognostic factors of thin cutaneous melanoma: An analysis of the central malignant melanoma registry of the german dermatological society","volume":"22","author":"Leiter","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108133759_b5-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jso.20079","article-title":"The natural course of cutaneous melanoma","volume":"86","author":"Leiter","year":"2004","journal-title":"J Surg Oncol"},{"key":"key20180108133759_b6-etm-0-0-3851","first-page":"81","article-title":"Duration of survival for disseminated malignant melanoma: Results of a meta-analysis","volume":"10","author":"Lee","year":"2000","journal-title":"Melanoma Res"},{"key":"key20180108133759_b7-etm-0-0-3851","first-page":"5386","article-title":"Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1","volume":"55","author":"Hewitt","year":"1995","journal-title":"Cancer Res"},{"key":"key20180108133759_b8-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1002\/j.1460-2075.1995.tb00148.x","article-title":"WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis","volume":"14","author":"Englert","year":"1995","journal-title":"EMBO J"},{"key":"key20180108133759_b9-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1101\/gad.9.17.2143","article-title":"The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis","volume":"9","author":"Maheswaran","year":"1995","journal-title":"Genes Dev"},{"key":"key20180108133759_b10-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1096-911X(199611)27:5<453::AID-MPO11>3.0.CO;2-B","article-title":"Functional properties of WT1","volume":"27","author":"Haber","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"key20180108133759_b11-etm-0-0-3851","first-page":"1429","article-title":"Induction of p21 by the Wilms' tumor suppressor gene WT1","volume":"57","author":"Englert","year":"1997","journal-title":"Cancer Res"},{"key":"key20180108133759_b12-etm-0-0-3851","first-page":"54","article-title":"A role for the Wilms tumor Protein WT1 in organ development","volume":"20","author":"Scholz","year":"2005","journal-title":"Physiology (Bethesda)"},{"key":"key20180108133759_b13-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10476","article-title":"Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers","volume":"100","author":"Oji","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180108133759_b14-etm-0-0-3851","first-page":"921","article-title":"Wilms' tumor suppressor gene (WT1) is expressed inprimary breast tumors despite tumor-specific promoter methylation","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108133759_b15-etm-0-0-3851","first-page":"1167","article-title":"High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients","volume":"8","author":"Miyoshi","year":"2002","journal-title":"Clin Cancer Res"},{"key":"key20180108133759_b16-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1349-7006.2003.tb01490.x","article-title":"Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer","volume":"94","author":"Oji","year":"2003","journal-title":"Cancer Sci"},{"key":"key20180108133759_b17-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00424-007-0340-1","article-title":"The Wilms' tumor suppressor WT1 is associated with melanoma proliferation","volume":"455","author":"Wagner","year":"2008","journal-title":"Pflugers Arch"},{"key":"key20180108133759_b18-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1600-0560.2009.01379.x","article-title":"WT 1 expression in nevi and melanomas: A marker of melanocytic invasion into the dermis","volume":"37","author":"Garrido-Ruiz","year":"2010","journal-title":"J Cutan Pathol"},{"key":"key20180108133759_b19-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2559.2007.02843.x","article-title":"WT1 as a complementary marker of malignant melanoma: An immunohistochemical study of whole sections","volume":"51","author":"Wilsher","year":"2007","journal-title":"Histopathology"},{"key":"key20180108133759_b20-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/CMR.0b013e3282efd3ae","article-title":"RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line","volume":"17","author":"Zamora-Avila","year":"2007","journal-title":"Melanoma Res"},{"key":"key20180108133759_b21-etm-0-0-3851","first-page":"751","article-title":"WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cells","volume":"3","author":"Zapata-Benavides","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180108133759_b22-etm-0-0-3851","first-page":"2473","article-title":"The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: In vitro and in vivo evaluation","volume":"8","author":"Yu","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"key20180108133759_b23-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jconrel.2004.04.018","article-title":"Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT)","volume":"98","author":"Maruyama","year":"2004","journal-title":"J Control Release"},{"key":"key20180108133759_b24-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"key20180108133759_b25-etm-0-0-3851","first-page":"489","article-title":"Optimization of technetium-99m-labeled PEG liposomes to image focal infection: Effects of particle size and circulation time","volume":"38","author":"Boerman","year":"1997","journal-title":"J Nucl Med"},{"key":"key20180108133759_b26-etm-0-0-3851","first-page":"181","article-title":"Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes","volume":"20","author":"Derycke","year":"2002","journal-title":"Int J Oncol"},{"key":"key20180108133759_b27-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.88.24.11460","article-title":"Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy","volume":"88","author":"Papahadjopoulos","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108133759_b28-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0014-4827(86)90056-X","article-title":"Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits","volume":"164","author":"Stavridis","year":"1986","journal-title":"Exp Cell Res"},{"key":"key20180108133759_b29-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-5793(87)80776-7","article-title":"The influence of coupling transferrin to liposomes or minibeads on its uptake and fate in leukemic L2C cells","volume":"216","author":"Vidal","year":"1987","journal-title":"FEBS Lett"},{"key":"key20180108133759_b30-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0898-6568(94)90063-9","article-title":"The binding of human serum transferrin to its specific receptor reconstituted into liposomes","volume":"6","author":"Di Giulio","year":"1994","journal-title":"Cell Signal"},{"key":"key20180108133759_b31-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jps.2600830211","article-title":"Coating of liposomes with transferrin: Physicochemical study of the transferrin-lipid system","volume":"83","author":"Egea","year":"1994","journal-title":"J Pharm Sci"},{"key":"key20180108133759_b32-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1042\/bst026s037","article-title":"Targeting of doxorubicin loaded liposomes to T-cells via the transferrin receptor","volume":"26","author":"Corley","year":"1998","journal-title":"Biochem Soc Trans"},{"key":"key20180108133759_b33-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.gt.3300674","article-title":"Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides","volume":"5","author":"Sim\u00f5es","year":"1998","journal-title":"Gene Ther"},{"key":"key20180108133759_b34-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138161280506230110111312","article-title":"Transferrin as a targeting ligand for liposomes and anticancer drugs","volume":"5","author":"Singh","year":"1999","journal-title":"Curr Pharm Des"},{"key":"key20180108133759_b35-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R","article-title":"Targeted drug delivery to C6 glioma by transferrin-coupled liposomes","volume":"51","author":"Eavarone","year":"2000","journal-title":"J Biomed Mater Res"},{"key":"key20180108133759_b36-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1023\/A:1010960900254","article-title":"Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo","volume":"18","author":"Ishida","year":"2001","journal-title":"Pharm Res"},{"key":"key20180108133759_b37-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1537-1891(02)00165-9","article-title":"Binding and uptake of transferrin-bound liposomes targeted to transferrin receptors of endothelial cells","volume":"39","author":"Voinea","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"key20180108133759_b38-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejpb.2004.12.009","article-title":"Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy","volume":"60","author":"Anabousi","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"key20180108133759_b39-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2013.01.016","article-title":"Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection","volume":"167","author":"Sharma","year":"2013","journal-title":"J Control Release"},{"key":"key20180108133759_b40-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2006.08.039","article-title":"Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells","volume":"329","author":"Kobayashi","year":"2007","journal-title":"Int J Pharm"},{"key":"key20180108133759_b41-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1073\/pnas.130187497","article-title":"Noninvasive gene targeting to the brain","volume":"97","author":"Shi","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108133759_b42-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C (T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108133759_b43-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(01)00324-8","article-title":"Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo\/radiotherapy","volume":"74","author":"Xu","year":"2001","journal-title":"J Control Release"},{"key":"key20180108133759_b44-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bjc.2014.287","article-title":"Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma","volume":"111","author":"Carlino","year":"2014","journal-title":"Br J Cancer"},{"key":"key20180108133759_b45-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/ejh.2011.e20","article-title":"The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions","volume":"55","author":"Pilloni","year":"2011","journal-title":"Eur J Histochem"},{"key":"key20180108133759_b46-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","article-title":"Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ and GNA11 dependent manner","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180108133759_b47-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0002-9440(10)64627-5","article-title":"Epigenetic PTEN silencing in Malignant Melanomas without PTEN Mutation","volume":"157","author":"Zhou","year":"2000","journal-title":"Am J Pathol"},{"key":"key20180108133759_b48-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1755-148X.2010.00773.x","article-title":"p53 prevents progression of nevi to melanoma predominantly through cellcycle regulation","volume":"23","author":"Terzian","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180108133759_b49-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pcmr.12180","article-title":"Targeting p53 in melanoma","volume":"27","author":"Box","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20180108133759_b50-etm-0-0-3851","first-page":"970","article-title":"Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells","volume":"7","author":"Miyagi","year":"1993","journal-title":"Leukemia"},{"key":"key20180108133759_b51-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0006-291X(02)00751-9","article-title":"Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation","volume":"295","author":"Zapata-Benavides","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180108133759_b52-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-010-0374-7","article-title":"Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: A potential role for IGF-1R de-repression","volume":"103","author":"Chen","year":"2011","journal-title":"J Neurooncol"},{"key":"key20180108133759_b53-etm-0-0-3851","first-page":"651","article-title":"Effect of WT1 antisense mRNA on the induction of apoptosis in ovarian carcinoma SKOV3 cells","volume":"32","author":"Huo","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"key20180108133759_b54-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/jid.2010.222","article-title":"Targeted nanoparticles deliver siRNA to melanoma","volume":"130","author":"Chen","year":"2010","journal-title":"J Invest Dermatol"},{"key":"key20180108133759_b55-etm-0-0-3851","first-page":"135","article-title":"Preparation of recombinant adenovirus Ad5\/F35 containing human WT1 and identification after recombinant adenovirus infected dendritic cells","volume":"30","author":"Zhang","year":"2014","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"key20180108133759_b56-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1089\/hum.2012.128","article-title":"Lentivirus-induced dendritic cells for immunization against high-risk WT1(+) acute myeloid leukemia","volume":"24","author":"Sundarasetty","year":"2013","journal-title":"Hum Gene Ther"},{"key":"key20180108133759_b57-etm-0-0-3851","first-page":"277","article-title":"Construction of recombinant lentiviral vector of Tie2-RNAi and its influence on malignant melanoma cells in vitro","volume":"27","author":"Shan","year":"2011","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"key20180108133759_b58-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0031-6997(24)01426-1","article-title":"Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors","volume":"51","author":"Drummond","year":"1999","journal-title":"Pharmacol Rev"},{"key":"key20180108133759_b59-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigen: A national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180108133759_b60-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/cgt.2009.35","article-title":"WT1 gene silencing by aerosol delivery of PEI:RNAi complexes inhibits B16-F10 lung metastases growth","volume":"16","author":"Zamora-Avila","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"key20180108133759_b61-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-006-9317-8","article-title":"Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53","volume":"83","author":"Clark","year":"2007","journal-title":"J Neurooncol"},{"key":"key20180108133759_b62-etm-0-0-3851","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3324\/haematol.11010","article-title":"Down-regulation of WT1\/+17AA gene expression using RNAi and modulating leukemia cell chemotherapy resistance","volume":"92","author":"Shen","year":"2007","journal-title":"Haematologica"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3851\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T21:54:23Z","timestamp":1749678863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,10,27]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.3892\/etm.2016.3851"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3851","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]}}}